Search research articles
Contact Us
Filters
Showing results (161-170 of 183) with videos related to
Page
of 19
Sort By:
Virology
|
February 1, 1987
Partial nucleotide sequence of St. Louis encephalitis virus RNA: structural proteins, NS1, ns2a, and ns2b
D W Trent, R M Kinney, B J Johnson, et al.
Vaccine
|
December 12, 2001
Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein
O Moriya, M Matsui, M Osorio, et al.
The American Journal of Psychiatry
|
December 1, 1990
Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients
E F Coccaro, E Kramer, Z Zemishlany, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 28, 2000
Mechanism of action of a pestivirus antiviral compound
S G Baginski, D C Pevear, M Seipel, et al.
The British Journal of Ophthalmology
|
December 24, 2004
Neural progenitor cells from postmortem adult human retina
E J Mayer, D A Carter, Y Ren, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 1998
Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection
D K Wong, D D Dudley, N H Afdhal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 29, 2004
Neutralizing antibody response during acute and chronic hepatitis C virus infection
C Logvinoff, M E Major, D Oldach, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping
|
January 1, 1997
The Chromosome 6 database at the Sanger Centre
A J Theaker, G L Maslen, C E Scott, et al.
Journal of Virology
|
April 1, 1995
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
M Battegay, J Fikes, A M Di Bisceglie, et al.
Clinical Pharmacology and Therapeutics
|
May 7, 2010
Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis
C M Rice, E A Mallam, A L Whone, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 183) with videos related to
Sort By:
Page
of 19
Virology
|
February 1, 1987
Partial nucleotide sequence of St. Louis encephalitis virus RNA: structural proteins, NS1, ns2a, and ns2b
D W Trent, R M Kinney, B J Johnson, et al.
Vaccine
|
December 12, 2001
Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein
O Moriya, M Matsui, M Osorio, et al.
The American Journal of Psychiatry
|
December 1, 1990
Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients
E F Coccaro, E Kramer, Z Zemishlany, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 28, 2000
Mechanism of action of a pestivirus antiviral compound
S G Baginski, D C Pevear, M Seipel, et al.
The British Journal of Ophthalmology
|
December 24, 2004
Neural progenitor cells from postmortem adult human retina
E J Mayer, D A Carter, Y Ren, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 1998
Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection
D K Wong, D D Dudley, N H Afdhal, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 29, 2004
Neutralizing antibody response during acute and chronic hepatitis C virus infection
C Logvinoff, M E Major, D Oldach, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping
|
January 1, 1997
The Chromosome 6 database at the Sanger Centre
A J Theaker, G L Maslen, C E Scott, et al.
Journal of Virology
|
April 1, 1995
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
M Battegay, J Fikes, A M Di Bisceglie, et al.
Clinical Pharmacology and Therapeutics
|
May 7, 2010
Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis
C M Rice, E A Mallam, A L Whone, et al.
Page
of 19